Verified peer comparison
Kymera Therapeutics vs Beneficient Financial Comparison
Direct answer
Kymera Therapeutics and Beneficient are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Kymera Therapeutics Revenue
- 39,200,000 USD
- Beneficient Revenue
- -39,125,000 USD
- Kymera Therapeutics Operating income
- -349,400,000 USD
- Beneficient Operating income
- -79,784,000 USD